# Zimmer Biomet Holdings, Inc. – Consensus ‘hold’ rating and 19.1% Upside Potential

- Link: https://www.directorstalkinterviews.com/zimmer-biomet-holdings-inc.consensus-hold-rating-and-19.1-upside-potential/4121132966
- Published: 2023-11-16T13:07:14+00:00
- Author: Charlotte Edwards

**Zimmer Biomet Holdings, Inc.** which can be found using ticker (ZBH) now have 
24 analysts in total covering the stock. The consensus rating is pointing to ‘hold’.
The range between the high target price and low target price is between $150.00 
and $99.00 and has a mean target at $128.75. Now with the previous closing price
of $108.07 this would indicate that there is a potential upside of 19.1%. Also worth
taking note is the 50 day moving average now sits at $110.65 and the 200 day MA 
is $126.14. The company has a market capitalization of 23.09B. The stock price is
currently at: $110.50 USD

 The potential market cap would be $27,511,303,012 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 48.68, revenue per share of $34.79
and a 4.24% return on assets.

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments
include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and 
markets orthopedic reconstructive products; sports medicine, biologics, extremities
and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical 
products; and a suite of integrated digital and robotic technologies that leverage
data, data analytics and artificial intelligence. Its other product category primarily
includes its robotic, surgical and bone cement products. Its products and solutions
help treat patients suffering from disorders of, or injuries to, bones, joints or
supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants,
Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip 
System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular 
System. Its S.E.T. product category includes sports medicine, biologics, foot and
others.

Share on: